<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effect of treatment with the <z:chebi fb="0" ids="29108">Ca2+</z:chebi> channel blocker and 5-HT2 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> levemopamil (recommended INN for (S)-emopamil) on the extent of ischaemic <z:hpo ids='HP_0002181'>brain oedema</z:hpo> was studied by magnetic resonance imaging in vivo </plain></SENT>
<SENT sid="1" pm="."><plain>Focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> was induced in spontaneously hypertensive rats by permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The treatment consisted of slow intravenous injections of an aqueous solution of levemopamil given immediately after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and again 2 h and 4 h later </plain></SENT>
<SENT sid="3" pm="."><plain>One group of animals (n = 17) received 3 x 2 mg/kg of levemopamil (total dose: 6 mg/kg) and another group (n = 13) received 3 x 4 mg/kg (total dose: 12 mg/kg) </plain></SENT>
<SENT sid="4" pm="."><plain>Saline was administered to the controls (n = 16) at corresponding times </plain></SENT>
<SENT sid="5" pm="."><plain>High-resolution T2-weighted spin echo images were obtained 24 h after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> from two transversal brain planes (4.5 mm and 6.5 mm dorsal to the interaural line) </plain></SENT>
<SENT sid="6" pm="."><plain>Dose-dependent reductions of <z:hpo ids='HP_0002181'>brain oedema</z:hpo> were achieved in both brain planes </plain></SENT>
<SENT sid="7" pm="."><plain>The lower dose of levemopamil reduced the extent of <z:hpo ids='HP_0000969'>oedema</z:hpo> significantly (P &lt; 0.05) by 20 +/- 3.7% in the upper and by 21 +/- 3.8% in the lower brain plane as compared to the controls (means +/- S.E.M.) </plain></SENT>
<SENT sid="8" pm="."><plain>The higher dose diminished the extent of <z:hpo ids='HP_0000969'>oedema</z:hpo> in the same planes by 30 +/- 3.5% and 31 +/- 4.0%, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>Dose-dependent reductions of <z:mpath ids='MPATH_124'>infarct</z:mpath> size, as determined by vital tissue staining using 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> (TTC), were observed in the levemopamil-treated groups </plain></SENT>
<SENT sid="10" pm="."><plain>Body temperature was not affected by levemopamil, suggesting direct cerebroprotection by this drug.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>